Why the Transurban (ASX:TCL) share price is sliding today

The Transurban Group (ASX: TCL) share price is sliding today following the release of the company's half-year results for FY 2021.

| More on:
ASX share price slide represented by urban street sign with car sliding

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Transurban Group (ASX: TCL) shares are sliding today following the release of the company's half-year results for FY2021 (H1 FY21). In early trade, the Transurban share price is down 1.65% to $13.14.

Let's take a look at what's impacting the toll road giant's shares.

Why is the Transurban share price in negative territory?

The Transurban share price is sinking this morning after the company announced significant losses across all key metrics.

According to its release, Transurban delivered an expected weak performance as COVID-19 heavily impacted traffic levels.

For the period ending 31 December, the company reported total revenue of $1,423 million. This reflected a 21.9% decrease on the prior corresponding period (pcp) caused primarily by a drop in toll revenue and construction revenue. Government-mandated restrictions limited passenger movement on road networks with average daily traffic down 17.8% over the first half.

In addition, tunnelling works hit a roadblock with spoil disposal issues at Transurban's West Gate Tunnel Project. After a project scheduling review, the company advised it does not expect to meet the 2023 completion target.

Earnings before interest, tax, depreciation and amortisation (EBITDA) sank to $792 million, representing a 21.5% fall on H1 FY20. While reduced traffic resulted in lower revenue, the group softened the blow with an additional $43 million received from the opening of new road assets and favourable changes in foreign exchange rates.

The group recorded a net loss of $414 million for the period compared to a $65 million profit during the pcp.

The Transurban share price is heading south after the board declared an interim dividend of 15 cents to be paid to eligible shareholders on 16 February. This will be funded through the company's free cash in H1 FY21, which stood at $467 million on 31 December.

Management commentary

Transurban CEO Scott Charlton spoke about the significant headwinds on the company's toll road networks. He said:

Transurban was significantly impacted as a result of COVID-19 during the first half of FY21, particularly in Melbourne and the Greater Washington Area where the virus and associated government restrictions were most severe. Pleasingly, traffic in Melbourne improved significantly through the half, with traffic in December down 19% compared to 66% in August, when restrictions were at their peak.

In markets where restrictions have lifted, for example Brisbane and Sydney, we have seen traffic largely recover to pre-COVID-19 levels, however it will remain sensitive to government responses and economic conditions.

Furthermore, Mr Charlton commented on the group's projects which have run into technical and commercial issues. He added:

We are progressing towards tunnelling commencement, however at this stage disposal sites participating in the D&C subcontractor led tender process would not be ready to accept tunnelling spoil soon enough to enable a 2023 completion. We remain committed to working with project parties to deliver this much-needed project for the Victorian community as quickly as possible.

A review of the Transurban share price

Over the past 12 months, the Transurban share price has shed close to 20% driven by poor trading conditions. Its shares hit a multi-year low of $9.10 in March, before rebounding to around the $13 mark.

Based on the current Transurban share price, the company commands a market capitalisation of around $36.5 billion.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Transurban Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two men laughing while bouncing on bouncy balls
Energy Shares

The two ASX energy stocks I think are set to rebound in 2025

After a shocking 2024, could these two energy companies power up again this year?

Read more »

A bored man sits at his desk, flat after seeing the latest news on the share market.
Technology Shares

Brainchip shares crash 10% on capital raising news

This semiconductor company is raising funds via a put option agreement again.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Broker Notes

This beaten down ASX 200 stock could rise 90%

Bell Potter thinks this stock could be dirt cheap after a recent selloff.

Read more »

Share Market News

5 things to watch on the ASX 200 on Tuesday

A good session is expected for Aussie investors today.

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

Healthy gains: 5 best ASX 200 healthcare shares of 2024

Four of the five best-performing ASX 200 healthcare stocks of 2024 more than doubled in value.

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Bellevue, BHP, Brainchip, and Peninsula Energy shares are tumbling today

These shares are starting the week in the red. But why?

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Block, DroneShield, EBR Systems, and Insignia shares are racing higher

These shares are starting the week on a high. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which All Ords ASX healthcare stock just surged 11% on FDA news

Investors are sending the ASX healthcare stock soaring on Monday.

Read more »